How H.B. Fuller Stock Has Been Trading Recently

H.B. Fuller (FUL) has seen relatively muted share performance lately, with the stock around $59.95 and negative returns over the past week, month, and past 3 months, despite a positive 1 year total return.

For context, the company carries a market value of about $3.27b and generates annual revenue of roughly $3.46b with net income of about $159.76m. This reflects its role as an established adhesives and specialty chemicals supplier.

Short term momentum has been weak, with a 7 day share price return of 4.58% and a 90 day share price return of 1.69%, even as the 1 year total shareholder return stands at 12.12%, while longer term total shareholder returns over 3 and 5 years remain negative.

If you want to see how other companies are priced and growing, it can help to widen the search to 17 top founder-led companies

With H.B. Fuller trading around $59.95, annual revenue of about $3.46b, net income near $159.76m, and a recent 1 year total return of 12.12%, is this a genuine value opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 15% Undervalued

At a last close of $59.95 versus a narrative fair value of $70.43, the most followed view sees H.B. Fuller trading at a meaningful discount, anchored on detailed earnings and margin assumptions.

The company's strategic initiatives, such as optimizing the portfolio mix and streamlining the manufacturing cost structure, aim to drive the business toward a greater than 20% EBITDA margin target, potentially enhancing profitability and earnings. H.B. Fuller's efforts in leveraging its unique operating model to reduce exposure to currency fluctuations and tariffs are designed to maintain a competitive edge and support margin expansion, which can improve net margins and financial stability.

Want to see what underpins that margin ambition and earnings path? The narrative leans on a tight blend of revenue growth, rising profitability, and a future earnings multiple that has been carefully calibrated against sector norms without assuming extreme optimism.

Result: Fair Value of $70.43 (UNDERVALUED)

However, this depends on challenges easing, because ongoing solar segment weakness and higher raw material costs could pressure margins and unsettle the earnings story.

Another Angle On Valuation

The narrative fair value of $70.43 paints H.B. Fuller as 15% undervalued, but the SWS fair ratio tells a different story. The current P/E of 20.4x sits above the fair ratio of 19x, even though it is well below both the Chemicals industry average and the peer average of about 30x. This suggests the market could tighten that gap in either direction. Is this a margin of safety or a sign that expectations are already quite full?

Next Steps

With mixed signals on valuation and sentiment, it makes sense to move quickly, test the assumptions against the data, and decide where you stand on 4 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you stop with just one stock, you could miss opportunities that better match your goals, risk comfort, and income needs, so keep broadening your watchlist intelligently.

• Target potential mispricings by scanning for companies that look attractively valued on quality metrics using the 50 high quality undervalued stocks.
• Strengthen your income stream by focusing on businesses with higher yields and resilient payouts through the 13 dividend fortresses.
• Lower portfolio stress by concentrating on companies with healthier finances and sturdier fundamentals via the solid balance sheet and fundamentals stocks screener (44 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.